citalopram has been researched along with Ischemic Attack, Transient in 2 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with citalopram (40 mg/kg i." | 1.28 | Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil. ( Kato, H; Kogure, K; Nakata, N, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraglund, KL | 1 |
| Mortensen, JK | 1 |
| Damsbo, AG | 1 |
| Modrau, B | 1 |
| Simonsen, SA | 1 |
| Iversen, HK | 1 |
| Madsen, M | 1 |
| Grove, EL | 1 |
| Johnsen, SP | 1 |
| Andersen, G | 1 |
| Nakata, N | 1 |
| Kato, H | 1 |
| Kogure, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy of Citalopram Treatment in Acute Stroke[NCT01937182] | Phase 2 | 642 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| Escitalopram and Language Intervention for Subacute Aphasia (ELISA)[NCT03843463] | Phase 2 | 88 participants (Anticipated) | Interventional | 2021-07-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for citalopram and Ischemic Attack, Transient
| Article | Year |
|---|---|
Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Citalopram; Denmark; Double-Blind Method; Early Medi | 2018 |
Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Citalopram; Denmark; Double-Blind Method; Early Medi | 2018 |
Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Citalopram; Denmark; Double-Blind Method; Early Medi | 2018 |
Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Citalopram; Denmark; Double-Blind Method; Early Medi | 2018 |
1 other study available for citalopram and Ischemic Attack, Transient
| Article | Year |
|---|---|
Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil.
Topics: Amino Acids; Animals; Citalopram; Clomipramine; Gerbillinae; Hippocampus; Ischemic Attack, Transient | 1992 |